We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · April 19, 2021

Platelet Activation Induced by Antiprothrombin Antibodies May Explain Anti-FXa Therapy Failure in Patients With Antiphospholipid Syndrome

Journal of Thrombosis and Haemostasis (JTH)


Additional Info

Journal of Thrombosis and Haemostasis (JTH)
Antiprothrombin Antibodies Induce Platelet Activation: A Possible Explanation for Anti-FXa Therapy Failure in Patients With Antiphospholipid Syndrome?
J. Thromb. Haemost. 2021 Mar 28;[EPub Ahead of Print], W Chayoua, PLR Nicolson, JCM Meijers, C Kardeby, L Garcia-Quintanilla, KMJ Devreese, B de Laat, SP Watson, PG de Groot

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading